HLY78

HLY78 is an activator of Wnt / beta-catenin used in studies of Wnt Signaling and Apoptosis. It is especially relevant in apoptosis, cancer, and cell signaling models, where defined compound exposure can be linked to beta-catenin-dependent transcription and developmental signaling and caspase-associated cell-death signaling and survival decisions.

By activating Wnt / beta-catenin, HLY78 can be used to examine beta-catenin-dependent transcription and developmental signaling and caspase-associated cell-death signaling and survival decisions. The signaling pathway modulator annotation adds relevance to pathway-reporter and mechanistic-phenotyping studies, together with downstream-response mapping in the same experimental setting. In apoptosis, cancer, and cell signaling models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving Wnt / beta-catenin
• Pathway perturbation studies connected to Wnt Signaling and Apoptosis
• Gain-of-function pathway-activation studies
• Pathway-reporter and mechanistic-phenotyping studies

Overall, HLY78 is appropriate when a defined chemical perturbant is needed to connect Wnt / beta-catenin with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in apoptosis, cancer, and cell signaling models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.